Article Information
History
- January 19, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Anthony Lemarié1,2,†,
- Vincent Lubrano3,4,
- Caroline Delmas1,
- Amélie Lusque5,
- Juan-Pablo Cerapio1,
- Marion Perrier1,
- Aurore Siegfried1,6,
- Florent Arnauduc1,2,
- Yvan Nicaise1,2,
- Perrine Dahan1,
- Thomas Filleron5,
- Muriel Mounier5,
- Christine Toulas1,7 and
- Elizabeth Cohen-Jonathan Moyal1,2,8,†
- 1CRCT, Université de Toulouse, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France
- 2UFR santé, Université de Toulouse III-Paul Sabatier, Toulouse, France
- 3TONIC, Université de Toulouse, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Toulouse Neuro Imaging Center, Toulouse, France
- 4CHU de Toulouse, Neurosurgery department, Toulouse, France
- 5Institut Claudius Regaud, IUCT-Oncopole, Biostatistics and Health Data Science Unit, Toulouse, France
- 6CHU de Toulouse, Anatomopathology department, Toulouse, France
- 7Institut Claudius Regaud, IUCT-Oncopole, Cancer Biology department, Molecular oncology division, Toulouse, France
- 8Institut Claudius Regaud, IUCT-Oncopole, Radiation Oncology department, Toulouse, France
- ↵†Corresponding authors: A Lemarié and E Cohen-Jonathan Moyal, RADOPT team, Inserm U1037 Toulouse Cancer Research Center CRCT, 2 av. Hubert Curien, 31100 Toulouse, FRANCE, Phone: +33 (0)5 82 74 16 06. E-mail: anthony.lemarie{at}inserm.fr; moyal.elizabeth{at}iuct-oncopole.fr